The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 30, 2014
Filed:
Dec. 09, 2008
Philippe Marc Louis Alard, Gent, BE;
Ian Richard Catchpole, Stevenage, GB;
Jonathan Henry Ellis, Stevenage, GB;
Susannah Karen Ford, Stevenage, GB;
Volker Germaschewski, Stevenage, GB;
Gerald Wayne Gough, Stevenage, GB;
Alan Peter Lewis, Stevenage, GB;
Peter Ernest Soden, Stevenage, GB;
Pamela Joan Thomas, Stevenage, GB;
Trevor Anthony Kenneth Wattam, Stevenage, GB;
Philippe Marc Louis Alard, Gent, BE;
Ian Richard Catchpole, Stevenage, GB;
Jonathan Henry Ellis, Stevenage, GB;
Susannah Karen Ford, Stevenage, GB;
Volker Germaschewski, Stevenage, GB;
Gerald Wayne Gough, Stevenage, GB;
Alan Peter Lewis, Stevenage, GB;
Peter Ernest Soden, Stevenage, GB;
Pamela Joan Thomas, Stevenage, GB;
Trevor Anthony Kenneth Wattam, Stevenage, GB;
Glaxo Group Limited, , GB;
Abstract
Antigen binding proteins that bind β-amyloid peptide, in particular human β-amyloid peptide; methods of treating diseases or disorders characterized by elevated β-amyloid levels or β-amyloid deposits, particularly Alzheimer's disease and diseases or disorders affecting the eye or optic nerve characterized by elevated β-amyloid levels or β-amyloid deposits, including age related macular degeneration and glaucoma type diseases and β-amyloid dependent cataract formation, with the antigen binding proteins; pharmaceutical compositions comprising the antigen binding proteins; and methods of manufacture.